Page 38 - Robert Kadlec News Today : Breaking News, Live Updates & Top Stories | Vimarsana

By Reuters Staff 2 Min Read (Reuters) - The U.S. government will buy 1.25 million additional doses of Regeneron Pharmaceuticals’ COVID-19 antibody cocktail for about $2.63 billion, bringing the total supply of the treatment to more than 1.5 million doses. FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. REUTERS/Brendan McDermid/File Photo The cocktail, a combination of two antibodies casirivimab and imdevimab, was authorized in November for emergency use by the U.S. Food and Drug...

10:12 AM   The U.S. Department of Health and Human Services has launched a treatment locator to help patients and providers find monoclonal antibody therapeutics for COVID-19. Housed at HHS' Protect Public Data Hub, the tool displays locations that have received shipments of therapeutics under the U.S. Food and Drug Administration authority within the past several weeks.   As of Monday, the locator displayed data from only 22 states. HHS notes that states must opt in to have facility information displayed, and that it would not display locations that received fewer than five courses of trea...

Coronavirus updates: LA County asking some to mask up at home; feds expand vaccine eligibility to speed up rollout Elinor Aspegren, Adrianna Rodriguez and Doyle Rice, USA TODAY Why widespread COVID-19 testing is crucial to fighting the coronavirus pandemic Replay Video USA TODAY is keeping track of the news surrounding COVID-19 as a pair of vaccines join the U.S. fight against a virus that has killed more than 376,000 Americans since the first reported fatality in February. Keep refreshing this page for the latest updates surrounding the coronavirus, including who is getting t...

Coronavirus Disease Weekly News 10January 2021 The news posted last week for the coronavirus 2019-nCoV (aka SARS-CoV-2), which produces COVID-19 disease, has been surveyed and some important articles are summarized here. The articles are more or less organized with general virus news and anecdotes first, then stories from around the US, followed by an increased number of items from other countries around the globe. Data continues to be quite eratic this week because of the holiday. We hope this is the last week for that. Economic news related to COVID-19 is found here. Please share this arti...

Share this article Share this article RADNOR, Pa. and GENEVA, Jan. 11, 2021 /PRNewswire/ -- NeuroRx, Inc. and RELIEF THERAPEUTICS Holding AG (SIX: RLF,OTCQB: RLFTF) ("Relief"), and the Quantum Leap Healthcare Collaborative ("Quantum Leap") of San Francisco announce that NeuroRx and QLHC have signed a Clinical Trial Participation Agreement for the inclusion of ZYESAMI™ (RLF-100 TM: aviptadil) in the I-SPY COVID-19 Clinical Trial.  Quantum Leap is the sponsor of the I-SPY COVID-19 Trial, a platform trial that is assessing multiple drugs for the treatment of patients with Critical COVID...